NCT06536283

Brief Summary

To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Sep 2024Dec 2026

First Submitted

Initial submission to the registry

July 31, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 16, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

2.3 years

First QC Date

July 31, 2024

Last Update Submit

April 28, 2026

Conditions

Opiophobia

Outcome Measures

Primary Outcomes (1)

  • To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.

    Use of opioids among a population of adults who underwent surgery for cancer.

    Through study completion, an average of 1 year.

Study Arms (1)

Opiophobia in Postsurgical Adults

Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires.

Other: 13-item Barriers Questionnaire (BQ-13)Other: Four-item Medication Adherence QuestionnaireOther: 14-item Hospital Anxiety and Depression Scale (HADS)

Interventions

13-item Barriers Questionnaire (BQ-13)OTHER

Given by questionnaire

Opiophobia in Postsurgical Adults
Four-item Medication Adherence QuestionnaireOTHER

Given by questionnaire

Opiophobia in Postsurgical Adults
14-item Hospital Anxiety and Depression Scale (HADS)OTHER

Given by questionnaire

Opiophobia in Postsurgical Adults

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Adult patient with cancer admitted for cancer-related surgery
  • inpatient surgical hospital stay lasting at least 23 hours
  • discharged home with a prescription for opioid analgesics
  • able to read, speak, and consent in English.

You may not qualify if:

  • Age less than 18 years
  • not discharged with a prescription for opioid analgesia to manage pain
  • individuals for whom there is documentation of inability to provide consent in the medical record.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Univerisity of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

Study Officials

  • Eileen Hacker, PHD,RN

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 2, 2024

Study Start

September 16, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Locations

US(1)